Management of IRIS

  • Authors: Irini Sereti, MD, MHS; Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)


Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362:697-706.[Abdool Karim 2010]

Abino JF, Peraldi R, Lepidi H, Luciani M, Girard PM. Bacillary splenitis (Bartonella henselae) during immune restoration in an HIV-infected patient. AIDS. 2002;16:1429-1430. [Abino 2002]

Aldeen T, Hay P, Davidson F, Lau R. Herpes zoster after infection in HIV-seropositive patients associated with highly active anti-retroviral therapy. AIDS. 1998;12:1719-1720. [Aldeen 1998]

Andrade BB, Hullsiek KH, Boulware DR, et al. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis. 2013;207:1379-1388....

Action required

Keywords: IRIS